High severity · published May 19, 2021
CVE-2017-17677
BMC Remedy 9.1SP3 is affected by authenticated code execution
8.8
CVSS
1.1%
EPSS
No
On KEV
Description
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
CVSS vector
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack vector
Network
Complexity
Low
Privileges
Low
User interaction
None
Confidentiality
High
Integrity
High
Availability
High
Scope
Unchanged
Exploitation
Is it being used?
Exploit prediction (EPSS)1.1% · higher than 64% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
RM
Remedy Mid-tier · Bmc
9.1 · source: NVD
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2017-17677
CVE.org
https://www.cve.org/CVERecord?id=CVE-2017-17677
Release Notes
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
Mailing List
https://seclists.org/fulldisclosure/2017/Oct/52
More from Remedy Mid-tier
9.8
CVE-2024-34399
**UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04
9.8
CVE-2017-17674
BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion
8.8
CVE-2018-18862
BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms, as demonstrated by…
6.1
CVE-2017-17678
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS)
5.3
CVE-2017-17675
BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking